Advanced search
Publication Cover
Cancer Investigation Volume 9, 1991 - Issue 1
Submit an article Journal homepage
2
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Reimbursement for Solid Tumor Autologous Bone Marrow Transplantation Trials: A Strategy for Ensuring Continuation of a Promising Therapy

Thomas R. Spitzer Bone Marrow Transplantation Program, Lombardi Cancer Research Center; Georgetown University, Department of Medicine, Washington, DC, 20007
,
Sandra M. Swain Bone Marrow Transplantation Program, Lombardi Cancer Research Center; Georgetown University, Department of Medicine, Washington, DC, 20007
,
Marc E. Lippman Bone Marrow Transplantation Program, Lombardi Cancer Research Center; Georgetown University, Department of Medicine, Washington, DC, 20007
&
H. Joachim Deeg Bone Marrow Transplantation Program, Lombardi Cancer Research Center; Georgetown University, Department of Medicine, Washington, DC, 20007
Pages 93-97 | Published online: 11 Jun 2009

References

  • Bone marrow autotransplantation in man. Report of an international cooperative study. Lancet 1986; 2: 960–962
  • Diagnostic and Therapeutic Technology and Assessment (DAT-TA). Autologous bone marrow transplantation. J Am Med Assoc 1986; 256: 98–101
  • Appelbaum FR. Hammering away at solid tumors. Cancer Treat Rep 1987; 71: 115–117
  • Phillips GL, Connors JM. Bone Marrow transplantation for malignant lymphoma. Progress in Bone Marrow Transplantation, RP. Gale, R. Champlin. Alan R Liss, Inc., New York 1987; 799–825
  • Canellos GP, Nadler L, Takvorian T. Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease. Semin Hematol 1988; 25: 58–65, suppl 2
  • Kersey JH, Weisdorf P, Nesbit ME, et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 37: 461–467
  • Yeager AM, Kaizer H, Santos GW, et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, usingex vivomarrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 1986; 315: 141–147
  • Phillips GL, Fay JW, Herzig GP, et al. Intensive 1,3bis(2-chlorethyl)-1-nitrosourea (BCNU), NSC 436 6650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer 1983; 52: 1792–1802
  • Lazarus H, Herzig R, Graham-Pole J, et al. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol 1983; 2: 359–367
  • Herzig RH, Phillips GL, Lazarus HM, et al. Intensive chemotherapy and autologous bone marrow transplantation for the treatment of refractory malignancies. Autologous Bone Marrow Transplantation: Procedeings of the First International Symposium. University of Texas, M.D. Anderson Hospital and Tumor Institute, Houston, TX 1984
  • Peters WP, Eder JP, Henner WD, et al. High-dose combination alkylating agents with autologous bone marrow support: A phase I trial. J Clin Oncol 1986; 4: 646–654
  • Antman K, Gale RP. Advanced breast cancer. High-dose chemotherapy and bone marrow autotransplants. Ann Intern Med 1988; 108: 570–574
  • Frei E, III, Canellos GP. Dose. A critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594
  • Henderson IC, Hayes DF, Gelman R. Dose-response in the treatment of breast cancer: A critical review. J Clin Oncol 1988; 6: 1501–1515
  • Peters WP, Shpall EJ, Jones RB, et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6: 1368–1376
  • Rudnick S, Cadman EC, Capizzi RL, et al. High-dose cytosine arabinoside in refractory acute leukemia. Cancer 1979; 44: 1189–1193
  • Herzig RH, Wolff GN, Lazarus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361–369
  • Wolff SN, Marion J, Stein RS, et al. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: A pilot study. Blood 1985; 65: 1407–1411
  • Pritchard J, Garmond S, Jones D, et al. Is high dose melphalan of value in treatment of advanced neuroblastoma? Preliminary results of a randomized trial by the European Neuroblastoma Study Group. Proc Am Soc Clin Oncol 1986; 5: 205
  • Gulati SC, Shank B, Black P, et al. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 1988; 6: 1303–1313
  • Welch HG, Larson EB. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 1989; 321: 807–812
  • Wittes RE. Paying for patient care in treatment research: Who is responsible?. Cancer Treat Rep 1987; 71: 107–113
  • Antman K, Schnipper LE, Frei E. The crisis in clinical cancer research: Third party insurance and investigational therapy. N Engl J Med 1988; 319: 46–48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.